FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
Nektar Therapeutics (NASDAQ: NKTR) is under heavy pressure this morning. Shares are down 8.6% on volume that is running 49x normal.
This morning, Bristol-Myers Squibb Company (NYSE: BMY) and Nektar Therapeutics... More
Bristol-Myers Squibb Company (NYSE: BMY) and Nektar Therapeutics (Nasdaq:... More

